Trending

AAPL

AMZN

$120.58 $1.08 0.89%

TSLA

$203.93 $2.77 1.38%

GOOG

$123.37 $1.27 1.02%

Main Feature, Stocks

24/7 MN (NASDAQ: REVB) REVELATION BIOSCIENCES shares are soaring at the open on a continuation of the news of Phase 2 efficacy. Shares are now up 92% this morning with 30,306 trades & 6.4 million in volume.

by 24/7 MarketNews Admin

Jul 25, 2022 at 7:00 AM

Revelation Biosciences Inc. Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

https://www.globenewswire.com/news-release/2022/07/22/2484694/0/en/Revelation-Biosciences-Inc-Announces-Topline-Data-for-Phase-1b-CLEAR-Clinical-Study-of-REVTx-99b-for-the-Treatment-of-Allergic-Rhinitis.html

RelatedNews

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Remark AI Awarded $6 million Rio De Janeiro police contract

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

LL Flooring Receives Unsolicited Buyout Offer

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

May 31, 2023

Remark AI Awarded $6 million Rio De Janeiro police contract

May 31, 2023

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

May 31, 2023

LL Flooring Receives Unsolicited Buyout Offer

May 31, 2023

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

May 31, 2023

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

24/7 MN (NASDAQ: REVB) REVELATION BIOSCIENCES shares are soaring at the open on a continuation of the news of Phase 2 efficacy. Shares are now up 92% this morning with 30,306 trades & 6.4 million in volume.

Revelation Biosciences Inc. Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

RelatedNews

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Remark AI Awarded $6 million Rio De Janeiro police contract

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

LL Flooring Receives Unsolicited Buyout Offer

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

Want more news like this? Check out our homepage!

Recent News

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Remark AI Awarded $6 million Rio De Janeiro police contract

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

LL Flooring Receives Unsolicited Buyout Offer

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Search by keyword

Add New Playlist